Wells Fargo
NPCE icon

Wells Fargo’s Neuropace NPCE Stock Holding History

Wells Fargo’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190K Sell
14,483
-18,605
-56% -$279K ﹤0.01% 4726
2025
Q4 		$511K Buy
33,088
+13,078
+65% +$175K ﹤0.01% 4481
2025
Q3 		$206K Buy
20,010
+4,145
+26% +$39.1K ﹤0.01% 4916
2025
Q2 		$177K Sell
15,865
-9,485
-37% -$119K ﹤0.01% 4840
2025
Q1 		$312K Buy
25,350
+18,867
+291% +$236K ﹤0.01% 4402
2024
Q4 		$72.5K Buy
6,483
+2,279
+54% +$19.8K ﹤0.01% 5356
2024
Q3 		$29.3K Sell
4,204
-2,166
-34% -$15.8K ﹤0.01% 5532
2024
Q2 		$48.2K Buy
6,370
+4,288
+206% +$43.3K ﹤0.01% 5309
2024
Q1 		$27.5K Buy
2,082
+2,001
+2,470% +$28.5K ﹤0.01% 5475
2023
Q4 		$835 Buy
81
+7
+9% +$56 ﹤0.01% 6269
2023
Q3 		$720 Sell
74
-149
-67% -$872 ﹤0.01% 6277
2023
Q2 		$1K Buy
223
+4
+2% +$18 ﹤0.01% 6321
2023
Q1 		$1.02K Buy
219
+151
+222% +$578 ﹤0.01% 6371
2022
Q4 		$101 Sell
68
-18
-21% -$40 ﹤0.01% 6791
2022
Q3 		$0 Buy
86
+43
+100% +$207 ﹤0.01% 7135
2022
Q2 		$0 Sell
43
-1,553
-97% -$10.3K ﹤0.01% 7263
2022
Q1 		$13K Sell
1,596
-2,475
-61% -$21.4K ﹤0.01% 6176
2021
Q4 		$41K Sell
4,071
-6,108
-60% -$79.3K ﹤0.01% 6063
2021
Q3 		$161K Sell
10,179
-42
-0.4% -$882 ﹤0.01% 5196
2021
Q2 		$243K Buy
+10,221
New +$237K ﹤0.01% 4947

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wells Fargo's NPCE Position: Q1 2026 in Review

Wells Fargo reduced its Neuropace (NPCE) stake by 56% in Q1 2026, selling an estimated $279K and leaving 14,483 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #4726.

Wells Fargo first reported a position in NPCE in Q2 2021 and has held it in 20 quarters since. The position peaked at $511K in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Wells Fargo held 14,483 shares of Neuropace worth $190K as of Q1 2026.
  • Wells Fargo sold 18,605 Neuropace shares in Q1 2026, an estimated $279K.
  • Neuropace made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4726 holding.
  • Wells Fargo first reported a position in Neuropace in Q2 2021 and has held it in 20 quarters since.
  • Wells Fargo's Neuropace position peaked at $511K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.